Literature DB >> 22392509

Idiopathic pyoderma gangrenosum: successful resolution with infliximab therapy and pro-inflammatory cytokines assessment.

Stefano R Del Giacco1, Davide Firinu, Maria Maddalena Lorrai, Loredana Serusi, Raffaella Meleddu, Maria Pina Barca, Monica Peralta, Paolo Emilio Manconi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22392509     DOI： 10.2340/00015555-1301

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  3 in total

1.  Infliximab drug and antibody levels in patients with dermatological conditions.

Authors:  L Elberdín; M Outeda; P Salvador; S Paradela; R M Fernández-Torres; R Iglesias; E Fonseca; I Martín
Journal:  Int J Clin Pharm       Date:  2015-01-23

2.  A Case of Recurrent Idiopathic Pyoderma Gangrenosum.

Authors:  Filipa David; Rafaela Lopes Freitas; Rute Brás-Cruz; Joana Rocha; Cristina Rosário
Journal:  Cureus       Date:  2022-05-18

3.  Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review.

Authors:  Hakim Ben Abdallah; Karsten Fogh; Rikke Bech
Journal:  Int Wound J       Date:  2019-01-03       Impact factor: 3.315
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.